Active substance: benzydamine hydrochloride

Additional information:
Benzydamine is an NSAID, belongs to the group of indazoles. It has an anti-inflammatory and local analgesic effect, has an antiseptic effect against a wide range of microorganisms, restores microcirculation. Benzydamine has an antibacterial and specific antimicrobial effect due to the rapid penetration of microorganisms through the membranes, followed by damage to cell structures, disruption of metabolic processes and cell lysosomes. It has an antifungal effect against Candida albicans.


Additional information:

Drug indication:

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies):

  • Gingivitis, glossitis, periodontal disease, stomatitis (including after radiation and chemotherapy);
  • Pharyngitis, laryngitis, tonsillitis;
  • Candidiasis of the oral mucosa (as part of combination therapy);
  • Calculous inflammation of the salivary glands;
  • After surgical interventions and injuries (tonsillectomy, jaw fractures);
  • After treatment and removal of teeth.

Form of production:

Spray d/local. Note: dosed 0.255 mg/1 dose: fl. 30 ml (176 doses).